These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5947351)

  • 21. [Hodgkin's disease: treatment specificities in childhood].
    Claude L; Schell M
    Cancer Radiother; 2009 Oct; 13(6-7):527-9. PubMed ID: 19783192
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hodgkin's disease clinical trial.
    Nickson JJ
    Cancer Res; 1966 Jun; 26(6):1279-83. PubMed ID: 5911092
    [No Abstract]   [Full Text] [Related]  

  • 23. Extended radiotherapy in advanced Hodgkin's disease. Hematologic aspects.
    Johnson RE; Foley HT; Steckel RJ; Glenn DW
    Arch Intern Med; 1966 Jul; 118(1):70-4. PubMed ID: 5940198
    [No Abstract]   [Full Text] [Related]  

  • 24. The investigation and management of Hodgkin's disease in the pregnant patient.
    Thomas PR; Biochem D; Peckham MJ
    Cancer; 1976 Sep; 38(3):1443-51. PubMed ID: 953978
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Progress in the treatment of Hodgkin's disease].
    Bernard J
    Cah Med; 1972 Nov; 13(14):1029-39. PubMed ID: 4646242
    [No Abstract]   [Full Text] [Related]  

  • 26. Don't throw out the baby with the bathwater: on optimizing cure and reducing toxicity in Hodgkin's lymphoma.
    Yahalom J
    J Clin Oncol; 2006 Feb; 24(4):544-8. PubMed ID: 16446326
    [No Abstract]   [Full Text] [Related]  

  • 27. [Myocardial infarction after mediastinal radiotherapy of Hodgkin's disease].
    Tres A; Fuertes MA; Callén L; Poderós C; Rodrigo G; Peleato A; Polo J; Gutiérrez M
    Rev Esp Oncol; 1984; 31(3):477-82. PubMed ID: 6546176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Patterns of care outcome studies in Hodgkin's disease: results of the national practice and implications for management.
    Hanks GE; Kinzie JJ; Herring DF; Kramer S
    Cancer Treat Rep; 1982 Apr; 66(4):805-8. PubMed ID: 7074651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Dose distribution in patients with Hodgkin's disease during conventional radiotherapy].
    Glińska H; Skolyszewski J
    Pol Przegl Radiol Med Nukl; 1971; 35(5):617-20. PubMed ID: 5003233
    [No Abstract]   [Full Text] [Related]  

  • 30. Vinblastine sulfate in Hodgkin's disease.
    Lacher MJ
    N Y State J Med; 1969 Mar; 69(6):808-14. PubMed ID: 5252740
    [No Abstract]   [Full Text] [Related]  

  • 31. Evidence for a tumoricidal dose level in the radiotherapy of Hodgkin's disease.
    Kaplan HS
    Cancer Res; 1966 Jun; 26(6):1221-4. PubMed ID: 5947345
    [No Abstract]   [Full Text] [Related]  

  • 32. Radiotherapy of Hodgkin's disease.
    Dawson WB
    Proc R Soc Med; 1972 Dec; 65(12):1109-10. PubMed ID: 4631266
    [No Abstract]   [Full Text] [Related]  

  • 33. Acute promyelocytic leukemia following ABVD (doxorubicin, bleomycin, vinblastine, and dacarbazine) and radiotherapy for Hodgkin's disease.
    Amadori S; Papa G; Anselmo AP; Fidani P; Mandelli F; Biagini C
    Cancer Treat Rep; 1983 Jun; 67(6):603-4. PubMed ID: 6190561
    [No Abstract]   [Full Text] [Related]  

  • 34. Radiation injuries of the gastrointestinal tract in Hodgkin's disease: the role of exploratory laparotomy and fractionation. A study of 19 cases observed in a series of 134 patients treated at the Institut Gustave Roussy from 1972 to 1982.
    Gallez-Marchal D; Fayolle M; Henry-Amar M; Le Bourgeois JP; Rougier P; Cosset JM
    Radiother Oncol; 1984 Aug; 2(2):93-9. PubMed ID: 6505288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Therapy of malignant lymphomas].
    Huber H; Gattringer C; Lechleitner M; Gyenes T; Frommhold H; Brittinger G; Braunsteiner H
    Wien Klin Wochenschr; 1983 Feb; 95(4):93-112. PubMed ID: 6342274
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term results of palliative and radical radiotherapy of Hodgkin's disease.
    Kaplan HS
    Cancer Res; 1966 Jun; 26(6):1250-3. PubMed ID: 5947348
    [No Abstract]   [Full Text] [Related]  

  • 37. Quality control of involved-field radiotherapy in patients with advanced Hodgkin's lymphoma (EORTC 20884).
    Aleman BM; Girinsky T; van der Maazen RW; Strijk S; Meijnders P; Bortolus R; Olofsen-van Acht MJ; Lybeert ML; Lievens Y; Eghbali H; Noordijk EM; Tomsic R; Meerwaldt JH; Poortmans PM; Smit WG; Pinna A; Henry-Amar M; Raemaekers JM; ;
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1184-90. PubMed ID: 15936157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase I study of involved-field radiotherapy preceding autologous stem cell transplantation for patients with high-risk lymphoma or Hodgkin's disease.
    Dawson LA; Saito NG; Ratanatharathorn V; Uberti JP; Adams PT; Ayash LJ; Reynolds CM; Silver SM; Schipper MJ; Lichter AS; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):208-18. PubMed ID: 15093918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiotherapy in Hodgkin's disease.
    Pinto JM
    Indian J Cancer; 1972 Dec; 9(4):318-20. PubMed ID: 4120635
    [No Abstract]   [Full Text] [Related]  

  • 40. Radiation therapy can still be used safely in combined modality approaches in patients with Hodgkin's lymphoma.
    Dabaja B; Cox JD; Buchholz TA
    J Clin Oncol; 2007 Jan; 25(1):3-5. PubMed ID: 17194900
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.